First Group of COVID-19 Vaccine Test Subjects Return Home in Wuhan


The first group of human test subjects for a new COVID-19 vaccine developed by the Chinese military have returned home following the completion of 14-day quarantine period.

On 31 March a total of four vaccine testing volunteers completed the observation period for a novel coronavirus vaccine and returned home from a military medical testing centre in Wuhan, according to a report from

All four of the volunteers were subject to a 14-day quarantine and observation period after receiving the vaccine on 16 March, and provided blood samples on the 7th and final day of their confinement.

Ac­cord­ing to a re­port from Sci­ence and Tech­nol­ogy Daily a to­tal of 108 vol­un­teers are par­tic­i­pat­ing in stage 1 test­ing of the trial novel coronavirus vaccine, all of whom are per­ma­nent res­i­dents of the Wuhan area.  

The Acad­emy of Mil­i­tary Med­ical Sci­ences and Hong Kong-listed CanSino Bio-B are re­spon­si­ble for hold­ing the tri­als, ac­cord­ing to in­for­ma­tion from the Chi­nese Clin­i­cal Trial Reg­istry.

The stage 1 test par­tic­i­pants are di­vided into three groups – a low dose group, a medium dose group and a high dose group. Each group is com­prised of 36 vol­un­teers. 

Ac­cord­ing to Sci­ence and Tech­nol­ogy Daily the vac­cine was de­vel­oped via ge­netic en­gi­neer­ing, us­ing repli­ca­tion-de­fec­tive hu­man type 5 ade­n­ovirus as a vec­tor and ex­press­ing the new coro­n­avirus S anti­gen.

Related stories

108 Vol­un­teers Sign up for Stage 1 COVID-19 Vac­cine Tri­als in Wuhan Held by CanSino Bio-B

COVID-19 Vac­cine Test­ing Com­mences in Wuhan

19 Chi­nese Drug Com­pa­nies Work­ing on Novel Coro­n­avirus Vac­cine

Coro­n­avirus Vac­cines En­ter An­i­mal Test­ing Phase: Chi­na’s Sci­ence Min­istry